High incidence of venous thrombosis in patients with moderate-to-severe COVID-19

被引:0
|
作者
Oleg Kerbikov
Pavel Orekhov
Ekaterina Borskaya
Natalia Nosenko
机构
[1] Federal State Research Clinical Center,
[2] FMBA of Russia,undefined
[3] Burnasyan Federal Medical Biophysical Center FMBA of Russia,undefined
来源
关键词
COVID-19; Venous thrombosis; Anticoagulants; Thrombosis;
D O I
暂无
中图分类号
学科分类号
摘要
Increasing evidence suggests that COVID-19 may be associated with venous thromboembolism, and much data exists regarding high incidence of venous thrombosis in critical COVID-19 patients. However, evidence on this complication in less severe patients is not widely available. The aim of this study was to investigate the incidence of deep-vein thrombosis (DVT) in patients with moderate-to-severe COVID-19, to assess the prevalence of DVT with duplex ultrasound, and to compare patients with DVT and those without it using lung computerized tomography (CT), clinical information and lab data. The subjects of this study were 75 consecutive patients (aged 27–92 y, median–63 y; 36 males and 39 females) with moderate-to-severe COVID-19. DVT was found in 15 patients (20%). The vast majority of those with DVT (13 patients, 86.7%) had thrombi in calf veins and 2 (13.3%) had ileofemoral thrombosis. High incidence of DVT (20%) is observed even in patients with moderate-to-severe COVID-19. These patients require early anticoagulation therapy as part of their treatment. Such therapy may be continued after hospital discharge and these patients may also require follow-up vein ultrasonography after recovery to rule out DVT.
引用
收藏
页码:344 / 347
页数:3
相关论文
共 50 条
  • [41] Incidence, Predictors, and Outcomes of Venous and Arterial Thrombosis in COVID-19: A Nationwide Analysis
    Agrawal, Ankit
    Bajaj, Suryansh
    Bhagat, Umesh
    Chandna, Sanya
    Arockiam, Aro Daniela
    El Dahdah, Joseph
    Gupta, Rahul
    Shekhar, Shashank
    Raj, Kavin
    Nayar, Divya
    [J]. CIRCULATION, 2023, 148
  • [42] Increased Incidence of Thrombosis in a Cohort of Cancer Patients with COVID-19
    Zavras, Phaedon D.
    Mehta, Vikas
    Goel, Sanjay
    Billett, Henny H.
    [J]. ACTA HAEMATOLOGICA, 2022, 145 (02) : 152 - 159
  • [43] Incidence of deep venous thrombosis in COVID-19 hospitalized patients during the first peak of the Italian outbreak
    Baccellieri, Domenico
    Bertoglio, Luca
    Apruzzi, Luca
    Ardita, Vincenzo
    D'Angelo, Armando
    Bossi, Matteo
    Rinaldi, Enrico
    Bilman, Victor
    Calvisi, Stefania
    Castagna, Antonella
    Galli, Laura
    Landoni, Giovanni
    Melissano, Germano
    Querini, Patrizia Rovere
    Tresoldi, Moreno
    De Cobelli, Francesco
    Zangrillo, Alberto
    Ciceri, Fabio
    Chiesa, Roberto
    [J]. PHLEBOLOGY, 2021, 36 (05) : 375 - 383
  • [44] Incidence and Risk Factors for Thrombosis in Cancer Patients with COVID-19
    Didier, Alexander J.
    Campbell, Andrew
    Nandwani, Swamroop V.
    Fahoury, Alan
    Arsene, Camelia
    [J]. BLOOD, 2023, 142
  • [45] Incidence of thrombosis and hemorrhage in hospitalized cancer patients with COVID-19
    Patell, Rushad
    Bogue, Thomas
    Bindal, Poorva
    Koshy, Anita
    Merrill, Mwanasha
    Aird, William C.
    Bauer, Kenneth A.
    Zwicker, Jeffrey I.
    [J]. JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2020, 18 (09) : 2349 - 2357
  • [46] Early but not late convalescent plasma is associated with better survival in moderate-to-severe COVID-19
    Briggs, Neima
    Gormally, Michael V.
    Li, Fangyong
    Browning, Sabrina L.
    Treggiari, Miriam M.
    Morrison, Alyssa
    Laurent-Rolle, Maudry
    Deng, Yanhong
    Hendrickson, Jeanne E.
    Tormey, Christopher A.
    Desruisseaux, Mahalia S.
    [J]. PLOS ONE, 2021, 16 (07):
  • [47] High prevalence of occult thrombosis in cases of mild/moderate COVID-19
    Chen, Budong
    Jiang, Chunguo
    Han, Bing
    Guan, Chunshuang
    Fang, Gaoli
    Yan, Shuo
    Wang, Kexin
    Liu, Ligai
    Conlon, Christopher P.
    Xie, Ruming
    Song, Rui
    [J]. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2021, 104 : 77 - 82
  • [48] Azvudine and nirmatrelvir-ritonavir in hospitalized patients with moderate-to-severe COVID-19: Emulation of a randomized target trial
    Zhou, Yiling
    Liu, Yi
    Jiang, Li
    Zhang, Renqing
    Zhang, Huohuo
    Shi, Qingyang
    Yang, Zhirong
    Mao, Yi
    Liu, Sha
    Yang, Zhibo
    Ding, Jialin
    Zhou, Yongzhao
    Ren, Bi
    He, Liping
    Zhao, Xing
    Li, Weimin
    Li, Sheyu
    Liu, Dan
    [J]. JOURNAL OF MEDICAL VIROLOGY, 2023, 95 (12)
  • [49] Low muscle mass and high visceral fat mass predict mortality in patients hospitalized with moderate-to-severe COVID-19: a prospective study
    de Lima Beltrao, Fabyan Esberard
    de Almeida Beltrao, Daniele Carvalhal
    Carvalhal, Giulia
    de Lima Beltrao, Fabyo Napoleao
    de Aquino, Igor Motta
    Brito, Thaise da Silva
    Paulino, Barbara Costa
    Aires, Elisa
    Viegas, Diana
    Hecht, Fabio
    Halpern, Bruno
    De Morais Pordeus, Liana Clebia
    Rodrigues Goncalves, Maria da Conceicao
    Ramos, Helton Estrela
    [J]. ENDOCRINE CONNECTIONS, 2022, 11 (10)
  • [50] Risk factors for mortality in hospitalized moderate-to-severe COVID-19 patients: A single-center retrospective study
    Bahadorizadeh, Leyla
    Fard, Soheil Rahmani
    Behnagh, Arman Karimi
    Kiapey, Seyed Ali Hashemi
    Saneii, Seyed Hassan
    Minaeian, Sara
    [J]. INTERNATIONAL ARCHIVES OF HEALTH SCIENCES, 2021, 8 (04) : 267 - +